Nanomaterials as a successor of antibiotics in antibiotic-resistant, biofilm infected wounds?

17Citations
Citations of this article
31Readers
Mendeley users who have this article in their library.

Abstract

Chronic wounds are a growing problem for both society and patients. They generate huge costs for treatment and reduce the quality of life of patients. The greatest challenge when treating a chronic wound is prolonged infection, which is commonly caused by biofilm. Biofilm makes bacteria resistant to individuals’ immune systems and conventional treatment. As a result, new treatment options, including nanomaterials, are being tested and implemented. Nanomaterials are particles with at least one dimension between 1 and 100 nM. Lipids, liposomes, cellulose, silica and metal can be carriers of nanomaterials. This review’s aim is to describe in detail the mode of action of those molecules that have been proven to have antimicrobial effects on biofilm and therefore help to eradicate bacteria from chronic wounds. Nanoparticles seem to be a promising treatment option for infection management, which is essential for the final stage of wound healing, which is complete wound closure.

Author supplied keywords

Cite

CITATION STYLE

APA

Nowak, M., & Barańska-Rybak, W. (2021, August 1). Nanomaterials as a successor of antibiotics in antibiotic-resistant, biofilm infected wounds? Antibiotics. MDPI. https://doi.org/10.3390/antibiotics10080941

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free